CDAM UK Ltd Has $33.21 Million Stake in Endava PLC Sponsored ADR $DAVA

CDAM UK Ltd lowered its stake in Endava PLC Sponsored ADR (NYSE:DAVAFree Report) by 7.7% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,167,932 shares of the company’s stock after selling 180,042 shares during the quarter. Endava accounts for approximately 5.5% of CDAM UK Ltd’s portfolio, making the stock its 11th largest position. CDAM UK Ltd owned approximately 3.67% of Endava worth $33,213,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Quantbot Technologies LP acquired a new stake in Endava in the first quarter worth $25,000. GAMMA Investing LLC raised its holdings in shares of Endava by 81.0% during the second quarter. GAMMA Investing LLC now owns 1,683 shares of the company’s stock valued at $26,000 after purchasing an additional 753 shares during the period. State of Wyoming boosted its position in shares of Endava by 112.7% during the 1st quarter. State of Wyoming now owns 2,367 shares of the company’s stock worth $46,000 after purchasing an additional 1,254 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Endava by 23.5% in the 1st quarter. Smartleaf Asset Management LLC now owns 3,620 shares of the company’s stock valued at $72,000 after buying an additional 689 shares during the period. Finally, Investors Research Corp increased its position in Endava by 7.4% in the 2nd quarter. Investors Research Corp now owns 11,950 shares of the company’s stock valued at $183,000 after buying an additional 825 shares in the last quarter. 62.23% of the stock is owned by institutional investors.

Endava Stock Performance

NYSE DAVA opened at $6.34 on Friday. The company has a fifty day moving average price of $8.34 and a 200-day moving average price of $12.03. The firm has a market cap of $356.09 million, a price-to-earnings ratio of 31.68 and a beta of 1.18. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.18 and a quick ratio of 2.18. Endava PLC Sponsored ADR has a 1 year low of $6.03 and a 1 year high of $34.94.

Analysts Set New Price Targets

Several brokerages have issued reports on DAVA. Zacks Research upgraded Endava from a “strong sell” rating to a “hold” rating in a report on Friday, November 7th. Needham & Company LLC lowered their target price on Endava from $12.00 to $9.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. William Blair downgraded shares of Endava from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 11th. Cowen restated a “hold” rating on shares of Endava in a research note on Friday, September 5th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Endava in a research note on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $16.43.

Read Our Latest Stock Report on DAVA

Endava Profile

(Free Report)

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

See Also

Institutional Ownership by Quarter for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.